TMEM105 and breast carcinoma: We further transfected miR-1208 mimics into TMEM105-overexpressing breast cancer cells or transfected miR-1208 inhibitors into TMEM105-knockdown breast cancer cells, which attenuated the effects of TMEM105 overexpression or knockdown on wound healing, respectively (Fig. 7A, B).